MCL-1 Degradation Mediated by JNK Activation via MEKK1/TAK1-MKK4 Contributes to Anticancer Activity of New Tubulin Inhibitor MT189

Abstract

Colchicine site-targeted tubulin inhibitors are a promising type of anticancer drugs. MT189 is a new derivative of MT119, a previously reported colchicine site-binding antitubulin agent. In this study, MT189 was demonstrated to retain the property of MT119 in disrupting microtubulin via binding to the colchicine site, causing mitotic arrest and inducing apoptosis, and to display 8.7-fold enhanced proliferative inhibition in a panel of cancer cells. MT189 was shown to elicit in vivo anticancer effects on MDA-MB-231 xenografts in nude mice, and the tumor growth was suppressed by 35.9% over 14 days. MT189 led to degradation of MCL-1, a member of the antiapoptotic BCL-2 protein family. Its overexpression reduced but its silenced expression increased the apoptotic induction followed by the treatment with MT189. Moreover, the treatment with MT189 caused activation of the MEKK1/TAK1-MKK4-JNK signaling pathway. The activated JNK resulted in phosphorylation of MCL-1, which facilitated its ubiquitination-mediated degradation. Our results show that MT189 inhibits microtubulin polymerization by binding to the colchicine site. Relief of apoptotic suppression by MCL-1 degradation together with mitotic arrest contributes to the anticancer activity of MT189. Mol Cancer Ther; 13(6); 1480-91. Ó2014 AACR.

Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution

“…Then the cells were subjected to the Cell Counting Kit 8 (CCK8) assays (Chinese hamster cells, Ewing sarcoma cells, HCC1937 and MDA-MB-436 cells) or by Sulforhodamine B (SRB) assays (all the other cells) as described previously [18, 19]. The inhibition rate (%) was calculated as: [1-(A450 treated /A450 control )] × 100%.…”

Chronic Deletion and Acute Knockdown of Parkin Have Differential Responses to Acetaminophen-induced Mitophagy and Liver Injury in Mice

“…The decreased Mcl-1 protein levels were reversed by a proteasome inhibitor, supporting the important role of the proteasome in regulating Mcl-1 levels in APAPtreated hepatocytes. Finally, Mcl-1 degradation has also been shown to be induced by JNK phosphorylation in HeLa cells (55). Parkin KO mice had reduced JNK activation, which may be linked to their increased Mcl-1 expression.…”

Triptolide Induces Cell Killing in Multidrug-Resistant Tumor Cells via CDK7/RPB1 Rather than XPB or p44

“…SK-OV-3 cells were treated with 1 mmol/L triptolide for the indicated times, and cells were treated as described previously (10).…”

“…We reported that specific compounds can directly kill MDR tumor cells without affecting the function of P-gp, such as the natural products salvicine (3,4), pseudolaric acid B (5, 6), methyl spongoate (7), tanshinone I (2,8), and synthetic small molecules YCH337 (9) and MT series (10)(11)(12). Among them, the MDRovercoming activities of natural products were associated with the regulation of certain transcription factors.…”